Oncolytics Biotech is trading 5.55% up at $0.63 in the supplied pre-market price context, with no clear company-specific catalyst identified.
- The stock closed at $0.60 on October 5, after the session ended down 5.40%.
- The company’s official news page lists August 18 as its latest release, with no October 5–6 announcement shown.
- The broader market is modestly higher, but that does not establish the reason for the stock’s move.